What is the official website of Pharmaconex Nigeria ?

The official website of Pharmaconex Nigeria is https://www.pharmaconex-exhibition.com/en1/Westafrica.html.

What is Pharmaconex Nigeria's cybersecurity risk score?

Pharmaconex Nigeria has an AI-generated cybersecurity risk score of 770 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Pharmaconex Nigeria experienced?

According to Rankiteo, Pharmaconex Nigeria currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Pharmaconex Nigeria been affected by any supply chain cyber incidents ?

According to Rankiteo, Pharmaconex Nigeria has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Pharmaconex Nigeria have SOC 2 Type 1 certification ?

According to Rankiteo, Pharmaconex Nigeria is not certified under SOC 2 Type 1.

Does Pharmaconex Nigeria have SOC 2 Type 2 certification ?

According to Rankiteo, Pharmaconex Nigeria does not hold a SOC 2 Type 2 certification.

Does Pharmaconex Nigeria comply with GDPR ?

According to Rankiteo, Pharmaconex Nigeria is not listed as GDPR compliant.

Does Pharmaconex Nigeria have PCI DSS certification ?

According to Rankiteo, Pharmaconex Nigeria does not currently maintain PCI DSS compliance.

Does Pharmaconex Nigeria comply with HIPAA ?

According to Rankiteo, Pharmaconex Nigeria is not compliant with HIPAA regulations.

Does Pharmaconex Nigeria have ISO 27001 certification ?

According to Rankiteo,Pharmaconex Nigeria is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Pharmaconex Nigeria operate in ?

Pharmaconex Nigeria operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Pharmaconex Nigeria have ?

Pharmaconex Nigeria employs approximately None employees people worldwide.

Does Pharmaconex Nigeria own any subsidiaries ?

Pharmaconex Nigeria presently has no subsidiaries across any sectors.

How many LinkedIn followers does Pharmaconex Nigeria have ?

Pharmaconex Nigeria's official LinkedIn profile has approximately followers.

What is the NAICS classification code for Pharmaconex Nigeria ?

Pharmaconex Nigeria is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Pharmaconex Nigeria have a Crunchbase profile ?

No, Pharmaconex Nigeria does not have a profile on Crunchbase.

Does Pharmaconex Nigeria have a LinkedIn profile ?

Yes, Pharmaconex Nigeria maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/pharmaconex-nigeria.

How many cybersecurity incidents has Pharmaconex Nigeria experienced ?

As of June 19, 2026, Rankiteo reports that Pharmaconex Nigeria has not experienced any cybersecurity incidents.

How many peer or competitor companies does Pharmaconex Nigeria have ?

Pharmaconex Nigeria has an estimated 5,692 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Pharmaconex Nigeria

Boost Score +25 with badge (5 left)

770

/1000

Fair

795

/1000

Fair

Pharmaconex Nigeria Vendor Cyber Rating & Cyber Score

pharmaconex-exhibition.com

Add Your Compliance Badge

Pharmaconex Nigeria – the latest expansion of the successful Pharmaconex event series. With a decade of success in Egypt, Pharmaconex is now taking the next step by introducing its one-of-a-kind platform to West Africa. In association with CPHI.

Pharmaconex Nigeria A.I CyberSecurity Scoring

Scoring History

Pharmaconex Nigeria

Pharmaconex Nigeria CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Pharmaconex Nigeria Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Pharmaconex Nigeria

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Pharmaconex Nigeria in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Pharmaconex Nigeria in 2026.

Incident Types Pharmaconex Nigeria vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Pharmaconex Nigeria in 2026.

Incident History - Pharmaconex Nigeria (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Pharmaconex Nigeria Subsidiaries

Pharmaconex Nigeria

Pharmaceutical Manufacturing

Website: https://www.pharmaconex-exhibition.com/en1/Westafrica.html

Company Size: 11-50 employees

Informa MarketsEvents Services

LEAPEvents Services

HIMSSNon-profit Organizations

HIMSS Global Health Conference & ExhibitionEvents Services

Global Health Exhibition - ملتقى الصحة العالميEvents Services

VIBE SAUDIEvents Services

Cityscape GlobalReal Estate

ESTAADEvents Services

Informa U.S. Boat ShowsEvents Services

Hong Kong Convention and Exhibition Centre (Management) LimitedEvents Services

ABASTUREvents Services

HOTELEXEvents Services

UBM Sinoexpo-ExpofinefoodEvents Services

UBM Sinoexpo-Hotel SuppliesEvents Services

UBM Sinoexpo-Wine & SpiritsEvents Services

UBM Sinoexpo-Coffee & TeaEvents Services

Fi IndiaEvents Services

Fi India AwardsFood and Beverage Manufacturing

Aircraft Interiors Middle East- AIMEAviation and Aerospace Component Manufacturing

Black Hat MEAEvents Services

InFlavourFood and Beverage Services

EXPOMAFEMachinery Manufacturing

Electric & Hybrid Vehicle Technology ExpoEvents Services

Cosmoprof AsiaEvents Services

WWETT ShowUtilities

CMA ShippingMaritime Transportation

ISSA Show North AmericaEvents Services

CAMWATERGovernment Administration

WHX DubaiEvents Services

EastPack LimitedFarming

GROWTECH. EventsEvents Services

VIETSTOCK Expo & ForumEvents Services

Art MiamiEvents Services

FIREX EgyptEvents Services

Mining IndonesiaMining

FHC - Shanghai Global Food Trade ShowEvents Services

AQUACULTURE VIETNAM EXPO & FORUMEvents Services

Global Aerospace SummitAirlines and Aviation

THE GREEN EXPO® MEXICOEvents Services

DesignConEvents Services

METALTECH & AUTOMEXMachinery Manufacturing

Adhesives & Bonding Expo EuropeEvents Services

Manufacturing by InformaEvents Services

PlasticsTodayTechnology, Information and Media

MD+DITechnology, Information and Media

Packaging DigestTechnology, Information and Media

MD&M Trade ShowsEvents Services

Pharmaceutical & Medical Packaging News (PMPN)Packaging and Containers Manufacturing

Design NewsTechnology, Information and Media

Powder & Bulk SolidsTechnology, Information and Media

MedTech WorldMedical Equipment Manufacturing

Qmed NewsMedical Equipment Manufacturing

EMDTMedical Equipment Manufacturing

HBA EventsPackaging and Containers Manufacturing

Cityscape BahrainReal Estate

Intertraffic AmericasFacilities Services

Informa Markets MalaysiaEvents Services

Super Terminal ExpoEvents Services

Untitled ArtArtists and Writers

Furniture ChinaEvents Services

Build Show LIVEResidential Building Construction

Informa Markets - MéxicoEvents Services

COTTM - China Outbound Travel & Tourism MarketEvents Services

Electric & Power IndonesiaAppliances, Electrical, and Electronics Manufacturing

HospitalarAdvertising Services

Informa Markets in the PhilippinesEvents Services

Beauty Expo AustraliaEvents Services

Sustainable Manufacturing ConferenceEvents Services

OSH IndiaPublic Safety

Construction Indonesia & Concrete Show SEAConstruction

Jakarta International ExpoEvents Services

UTECH LAS AMÉRICASPlastics and Rubber Product Manufacturing

TOC AsiaEducation

Client Solutions - North AmericaEvents Services

Newport International Boat ShowEvents Services

Nigeria EnergyEvents Services

Water IndonesiaEvents Services

OSH BangladeshEvents Services

Informa Markets - Infrastructure & ConstructionEvents Services

Medlab Middle East by BeelalRetail Health and Personal Care Products

The Battery Show EuropeAppliances, Electrical, and Electronics Manufacturing

The Battery ShowEvents Services

Electric & Hybrid Vehicle Technology Expo EuropeAppliances, Electrical, and Electronics Manufacturing

Informa Markets in AsiaEvents Services

APLFEvents Services

HOFEXFood and Beverage Services

The Battery Show AsiaEvents Services

Data Center AsiaEvents Services

Natural & Organic AsiaEvents Services

Restaurant, Bar & Café Hong KongEvents Services

Concrete ShowConstruction

Autotech EgyptMotor Vehicle Manufacturing

World of ConcreteConstruction

Gulf Print & PackPrinting Services

Thermal Management ExpoEvents Services

Pharmapack EuropeEvents Services

Seatrade CruiseEvents Services

F&B@SeaFood and Beverage Services

PharmaconexEvents Services

Loading…

Pharmaconex Nigeria Similar Companies

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Lupin

lupin.com

Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women’s health. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 23,000 professionals. Lupin is committed to improving patient health outcomes through its subsidiaries – Lupin Diagnostics, Lupin Digital Health, and Lupin Manufacturing Solutions.

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Fresenius Kabi

fresenius-kabi.com

As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Loading…

NEWS

Pharmaconex Nigeria CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-56078

SUMMARY

PraisonAI before 1.5.115 contains a path traversal vulnerability in MultiAgentMonitor that fails to sanitize agent IDs when building file paths. Attackers can include traversal sequences like ../ in agent IDs to read, write, or overwrite arbitrary files, enabling sensitive disclosure, denial of service, or code execution.

Published

Date2026-06-18

Updated

Date2026-06-18

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-56077

SUMMARY

PraisonAI before 1.5.115 contains an information disclosure vulnerability in the MultiAgentLedger component that allows attackers to access sensitive data by registering agents with duplicate IDs. Attackers can exploit the lack of agent ID uniqueness enforcement to share ledger instances and expose system prompts and conversation history between agents.

Published

Date2026-06-18

Updated

Date2026-06-18

RISK INFORMATION (Score: 6.5)

cvss3

Base Score: 6.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

cvss4

Base Score: 7.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

2.8

REFERENCES

CVE-2026-56076

SUMMARY

PraisonAI before 1.5.128 contains a cross-origin agent execution vulnerability in the AGUI endpoint that allows remote attackers to trigger arbitrary agent execution. The POST /agui endpoint lacks authentication and hardcodes Access-Control-Allow-Origin: * headers, combined with Starlette's Content-Type-agnostic JSON parsing, enabling attackers to bypass CORS preflight checks via simple requests and exfiltrate sensitive agent responses including tool execution results and environment data.

Published

Date2026-06-18

Updated

Date2026-06-18

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

2.8

REFERENCES

CVE-2026-56075

SUMMARY

PraisonAI before 4.5.128 contains an arbitrary shell command execution vulnerability where the UI modules hardcode approval_mode to auto, overriding administrator configuration from PRAISON_APPROVAL_MODE environment variable. Authenticated attackers can instruct the LLM agent to execute arbitrary shell commands via subprocess.run with shell=True, bypassing the manual approval gate and insufficient command sanitization blocklists.

Published

Date2026-06-18

Updated

Date2026-06-18

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

CVE-2026-56074

SUMMARY

PraisonAI before 1.5.128 caches tool approval decisions by tool name only, not by invocation arguments, allowing subsequent execute_command calls to bypass approval prompts. Attackers can exploit this by obtaining initial approval for a benign command, then silently exfiltrate API keys and credentials via subsequent shell commands without user consent.

Published

Date2026-06-18

Updated

Date2026-06-18

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N

cvss4

Base Score: 6.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:H/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…